IRWD
Ironwood Pharmaceuticals Inc
3.90$
+3.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.4% | +25.5% | -25.6% | -70.5% | +53.9% | +31.2% | -175.5% | – | +56.7% | -93.1% | +1,038.0% | – | |
| – | +1.0% | +0.2% | -1.4% | +0.2% | -4.3% | -1.2% | -2.5% | +1.7% | -3.2% | -3.7% | +3.2% | – | |
| – | +10.1% | -3.7% | +2.2% | -2.8% | -45.2% | +15.9% | -14.5% | -20.2% | +231.1% | -69.5% | -11.4% | – | |
| – | – | – | -66.0% | -193.2% | – | – | -217.2% | – | – | -181.4% | – | – | |
| – | +330.6% | -67.8% | -14.7% | -72.4% | +0.0% | +93.8% | -93.5% | +0.0% | -50.0% | -100.0% | – | – | |
| – | -81.5% | -98.4% | -14.7% | -72.4% | +0.0% | +93.8% | -93.5% | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -40.0% | -100.0% | – | – | – | – | – | – | |
| – | -32.1% | -69.4% | +217.4% | -45.0% | -45.2% | – | +1,366.7% | -100.0% | – | -100.0% | – | – | |
| – | – | – | -154.5% | – | – | +5,624.7% | -178.5% | – | +57.8% | -93.3% | -2,918.4% | – | |
| – | +9.9% | +26.1% | -25.6% | -70.5% | +54.2% | +31.0% | -175.6% | – | +56.7% | -93.1% | +1,038.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.